Aker BioMarine has appointed Aaron Kramer as new Chief Financial Officer under the process of management alteration. Kramer said that his main focus will one business development and strategy.He told that the company is now stressing its core activities: harvesting krill and processing this unique natural resource into high-value, bioactive products for human health and wellbeing markets and niche products for the aquaculture industry. Operational efficiency will also be sharpened by our management changes.
Kjell Inge Røkke, the CEO of Aker BioMarine, informed that it is regtreable that the company’s managerial changes have impacted such highly skilled colleagues. He made it clear that he is in charge on an interim basis, yet will remain heavily involved in the company’s development in the time ahead. According to Rokke the main goal is to forge the company’s ground-breaking efforts to deliver krill-based niche products for aquaculture applications, dietary supplements, and food additives in international growth markets.
Rokke also said that the appointment of Aaron Kramer as CFO is perfect as he is thoroughly familiar with Aker BioMarine’s operations. He told that they are considering various opportunities during this intensive period. Soon, key conclusions will be drawn, and we have scheduled a Capital Markets Day meeting with shareholders, analysts, and other interested parties in Oslo on 17 September 2008.
